FindTrial
Sign In

Pharmacokinetic study of vancomycin and meropenem and a pilot paediatric antibiotic stewardship program

Pharmacokinetic study of vancomycin and meropenem and a pilot paediatric antibiotic stewardship program

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081254
Enrollment
Unknown
Registered
2024-02-27
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Part 1:Nil
Part 2:Nil
Part 3:Nil

Sponsors

Department of Microbiology/CUHK
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria (Part 1): Patients in NICU and PICU and other paediatric units prescribed with intravenous vancomycin Inclusion criteria (Part 2): Patients in NICU and PICU and other paediatric units prescribed with intravenous meropenem Inclusion criteria (Part 3): Receipt of at least one of the selected antibiotics (intravenous vancomycin or intravenous meropenem) for at least 48 hours

Exclusion criteria

Exclusion criteria: Exclusion criteria (Part 1): Age more than 18 years Patients with extreme prematurity (born before 28 weeks of pregnancy) Subject’s parent or guardian who is not willing to sign informed consent Exclusion criteria (Part 2): Age more than 18 years Patients with extreme prematurity (born before 28 weeks of pregnancy) Subject’s parent or guardian who is not willing to sign informed consent Exclusion criteria (Part 3) Age more than 18 years

Design outcomes

Primary

MeasureTime frame
The PK/PD target of vancomycin (AUC/MIC);A pilot paediatric ASP program;The PK/PD target of meropenem (T>MIC);—

Countries

China

Contacts

Public ContactNg Wai Yin

Chinese University of Hong Kong

ritang@cuhk.edu.hk+852 3505 6959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026